EBV Peptide-Derived Vaccine Significantly Enhanced In Vitro Cytotoxicity Against EBV-Positive B-Cell Lymphoma (EBV-BL) Treatment Using TMV-Based Delivery System
Author Type(s)
Faculty, Resident/Fellow
Document Type
Abstract
Publication Date
7-2018
Journal Title
Cancer Research
Department
Pediatrics
Second Department
Health Behavior and Community Health
Recommended Citation
Tiwari, A. A., McCormick, A., Edani, D., Newman, A., Azmy, C., Ayello, J., Klein, C., & Cairo, M. S. (2018). EBV Peptide-Derived Vaccine Significantly Enhanced In Vitro Cytotoxicity Against EBV-Positive B-Cell Lymphoma (EBV-BL) Treatment Using TMV-Based Delivery System. Cancer Research, 78 (13 Suppl.), 2565. https://doi.org/10.1158/1538-7445.AM2018-2565